One child in the AL tablets arm developed severe anaemia (Hb < 5.0 g/dl) on Day 1 and was withdrawn from treatment while another child in the AL suspension arm developed convulsions on Day 0 and received treatment for severe malaria. This evidence concerns the gene GSTM1 and anemia.